CyberKnife® for Prostate Cancer

The CyberKnife robotic radiosurgery system is a widely used form of nonsurgical prostate stereotactic body radiation therapy (SBRT). The American Society for Radiation Oncology (ASTRO) believes that enough clinical evidence exists so that SBRT should be considered an appropriate treatment option for select patients with low- to intermediate-risk prostate cancer. CyberKnife is designed to avoid healthy tissue and critical anatomy, therefore reducing side effects such as erectile dysfunction, urinary and bowel complications.

John Bedwinek MD, FACR, FASTRO, FACRO

Certified SpaceOAR Application Specialist

Board-certified in radiation oncology and therapeutic radiology, John Bedwinek, M.D., is a graduate of Columbia University and completed his fellowship at the prestigious University of Texas M.D. Anderson Cancer Center.

Dr. Bedwinek has more than 30 years of experience in patient care with a special interest in prostate cancer and CyberKnife treatment. He has been published in more than 50 publications.

He has been named in both St. Louis’ Best Doctors list and in America’s Best Doctors list since their inception in 1997. He has been awarded fellowships in the American College of Radiology, the College of Radiation Oncology and the American Society of Radiology and Oncology.

Dr. Bedwinek is a certified SpaceOAR Application Specialist. To find out more about SpaceOAR click here.

Key Advantages of CyberKnife for Prostate Cancer

  • Only 5 Treatments
  • Pinpoint Accuracy
  • Few Side Effects
  • Non-Invasive
  • No Recovery Time

National Comprehensive Cancer Network Guidelines

Patient Testimonials

Mike’s Story

Dr. Louis Heuser’s Story

Latest News

Read more prostate related articles and news stories.

Speak with one of our team members about how we can help.

Follow Us